Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis
International Immunopharmacology · 2026-06 · 179 · 116565
DOI: 10.1016/j.intimp.2026.116565 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Xiangxiang Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Third Affiliated Hospital of Wenzhou Medical University, No. 108 Wansong Road, Ruian, Wenzhou, Zhejiang 325200, China. Hauptthemen laut MEDLINE: Osteoarthritis, Anti-Inflammatory Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Affiliated Hospital of Wenzhou Medical University, No. 108 Wansong Road, Ruian, Wenzhou, Zhejiang 325200, China.
- The Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, China.
- The Third Affiliated Hospital of Wenzhou Medical University, No. 108 Wansong Road, Ruian, Wenzhou, Zhejiang 325200, China. Electronic address: 9003214@qq.com.
- Shanghai Fengxian District Central Hospital, No.6600 Nanfeng Road, 201499 Shanghai, China. Electronic address: surgll@163.com.
- The Third Affiliated Hospital of Wenzhou Medical University, No. 108 Wansong Road, Ruian, Wenzhou, Zhejiang 325200, China. Electronic address: 82558831@163.com.
Zitieren
APA
Huang, X., Zhang, J., Chen, N., Huang, B., Zhao, Y., Zhu, C., Zhang, S., Xia, J., Zhang, L., Liu, L., & Lin, X. (2026). Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis. International Immunopharmacology, 179, 116565. https://doi.org/10.1016/j.intimp.2026.116565
Vancouver
Huang X, Zhang J, Chen N, Huang B, Zhao Y, Zhu C, et al. Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis. International Immunopharmacology. 2026;179:116565. doi:10.1016/j.intimp.2026.116565
BibTeX
@article{Huang2026,
author = {Huang, Xiangxiang and Zhang, Jialuo and Chen, Nuo and Huang, Binquan and Zhao, Yan and Zhu, Chenggong and Zhang, Shuliang and Xia, Jiarui and Zhang, Lingzhou and Liu, Lei and Lin, Xiaoyong},
title = {Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis},
journal = {International Immunopharmacology},
year = {2026},
volume = {179},
pages = {116565},
doi = {10.1016/j.intimp.2026.116565}
}
EUVIMED